JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 48(2014) N 1 p. 52-57; DOI 10.1134/S0026893314010099 Full Text

V.I. Loginov1,5*, M.V. Atkarskaya2, A.M. Burdennyy 1,2**, T.M. Zavarykina2, T.P. Kazubskaya3, V.V. Nosikov2,5, E.A. Braga4,5, G.P. Zhizhina 2

Association of Arg72Pro of TP53 and T309G of MDM2 Genes Polymorphisms with Non-Small-Cell Lung Cancer in Russians of the Moscow Region

1Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow, 125315, Russia
2Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Moscow, 119334, Russia
3Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, 115478, Russia
4Research Center of Medical Genetics, Russian Academy of Medical Sciences, Moscow, 115478, Russia
5GosNIIgenetika State Research Center, Moscow, 117545, Russia

*loginov7@genetika.ru
**burdennyy@gmail.com
Received - 2013-05-17; Accepted - 2013-07-04

Association of ТР53 Arg72Pro and MDM2 T309G polymorphic markers with the risk of non-small-cell lung cancer was studied in a Russian population of the Moscow region. The minor Pro/Pro genotype of Arg72Pro and the TG genotype of T309G were associated with non-small-cell lung cancer (OR = 5.46, p = 8 х 10-6 and OR = 7.38, p = 0.0001, respectively). Both Pro/Pro and TG genotypes were also strongly associated with lung adenocarcinoma (OR = 8.71, p = 3 х 10-6 and OR = 8.13, p = 0.003, respectively) and squamous-cell lung carcinoma (OR = 4.2, p = 0.001 and OR = 7.02, p = 0.002, respectively). Finally, combined susceptible genotypes of ТР53 and MDM2 polymorphisms Arg72Pro and T309G were reliably associated with non-small-cell lung cancer and both its subtypes (OR = 7.9, p = 0.01; OR = 9.12, p = 0.02; OR = 7.31, p = 0.03, respectively).

Arg72Pro and T309G polymorphic markers, TP53, MDM2, non-small-cell lung cancer, adenocarcinoma, squamous-cell lung carcinoma



JMB-FOOTER RAS-JOURNALS